A detailed history of Aquatic Capital Management LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Aquatic Capital Management LLC holds 700 shares of BMEA stock, worth $4,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$4,970
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.14 - $15.3 $2,898 - $10,710
700 New
700 $3,000
Q2 2023

Aug 14, 2023

BUY
$21.66 - $41.8 $6,498 - $12,540
300 New
300 $7,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $208M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.